4//SEC Filing
Cruse Michael 4
Accession 0001209191-22-016541
CIK 0001637715other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 9:51 PM ET
Size
5.5 KB
Accession
0001209191-22-016541
Insider Transaction Report
Form 4
Cruse Michael
Senior VP-Corporate Operations
Transactions
- Award
Stock option (right to buy)
2022-03-02+25,000→ 25,000 totalExercise: $4.58Exp: 2032-03-01→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares vest in a series of 48 successive equal monthly installments measured from March 2, 2022, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.
Documents
Issuer
Reneo Pharmaceuticals, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001854179
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 9:51 PM ET
- Size
- 5.5 KB